Research

Clinical Protocols:

• MSG-001: A Randomized double-Blind, Placebo Controlled Trial of Caspofungin Prophylaxis Followed by pre-emptive Therapy for Invasive Candidiasis in High-risk Adults in the Critical Care Setting

• Phase IV Open Label Non Comparative Trial of IV Anidulafungin Followed by Oral Azole Therapy for the Treatment of Candidemia and Invasive Candidiasis

• HIV+ Solid Organ Transplant Multi Site Study

• DEFEAT Mucor, The Deferasirox (Exjade)-AmBisome Therapy for Mucormycosis Study, Phase II Study

• Prospective Evaluation of Albuminuria in HIV Infection

• Association Between Beta Glucan Level and Burn Body Surface Area

• Collaborative Studies with National Institutes of Health

• Immune Reconstitution Syndrome Research Study in HIV-Infected Patients Taking Antivirals

• An Investigation into HbA1C as an Indicator of Glycemic Control in HIV-Infected Patients and Potential  Antiviral Agents

• Prospective Evaluation of Albuminuria in HIV-positive Patients

Laboratory Based Protocols:

• In Vitro Human Blood Barrier Model for Pharmacokinetic Studies

• Echinocandin-resistant C. albicans in a Neutropenic Rabbit Model: A Comparison of Anidulafungin and Caspofungin Pharmacokinetics and Clinical Efficacy

• Microbiological and Clinical Evaluation of Nanoparticle and Silver Ion impregnated  Garments

• Role of Apoptosis in Amphotericin B Associated Nephrotoxicity